Search

Hauser, RA, A Ellenbogen, S Khanna, S Gupta, and NB Modi. 2018. “Onset and Duration of Effect of Extended-Release Carbidopa-Levodopa in Advanced Parkinson’s Disease. Neuropsychiatr Dis Treat 2018;14:839-845.”. Neuropsychiatr Dis Treat.

Fernandez, HH, D Stamler, MD Davis, SA Factor, RA Hauser, J Jimenez-Shahed, WG Ondo, LF Jarskog, SW Woods, and D Bega. 2019. “Long-Term Safety and Efficacy of Deutetrabenazine for the Treatment of Tardive Dyskinesia. J Neurol Neurosurg Psychiatry 2019;90:1317-1323.”. J Neurol Neurosurg Psychiatry.

Francois, C, GJ Rowse, LA Hewitt, P Vo, and RA Hauser. 2016. “Analysis of Number Needed to Treat for Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension. BMC Neurol 2016;16:143.”. BMC Neurol.

Hauser, RA, H Reichmann, M Lew, A Asgharian, C Makumi, and KJ Shulman. 2011. “Long-Term, Open-Label Study of Once-Daily Ropinirole Prolonged Release in Early Parkinson’s Disease. Int J Neurosci 2011;121:246-53.”. Int J Neurosci.

Pahwa, R, KE Lyons, RA Hauser, S Fahn, J Jankovic, E Pourcher, A Hsu, M O’Connell, S Kell, and S Gupta. 2014. “Randomized Trial of IPX066, Carbidopa/Levodopa Extended Release, in Early Parkinson’s Disease. Parkinsonism Relat Disord 2014;20:142-8.”. Relat Disord.

Hauser, RA, P Auinger, and Parkinson Study Group. 2012. “Determination of Minimal Clinically Important Change in Early and Advanced Parkinson’s Disease. Mov Disord 2011;26:813-8.”. Mov Disord.

Seo, Serah, Vishal Bharmauria, Adrian Schütz, Xiaogang Yan, Hongying Wang, and John Douglas Crawford. 2024. “Multiunit Frontal Eye Field Activity Codes the Visuomotor Transformation, But Not Gaze Prediction or Retrospective Target Memory, in a Delayed Saccade Task”. ENeuro.

Sumarac, Srdjan, Jinyoung Youn, Conor Fearon, Luka Zivkovic, Prerana Keerthi, Oliver Flouty, Milos Popovic, et al. 2024. “Clinico-Physiological Correlates of Parkinson’s Disease from Multi-Resolution Basal Ganglia Recordings”. Npj Parkinson’s Disease.

Poewe, W, O Rascol, P Barone, RA Hauser, Y Mizuno, M Haaksma, L Salin, N Juhel, and AH Shapira. 2011. “Extended-Release Pramipexole in Early Parkinson Disease: A 33-Week Randomized Controlled Trial”. Neurology.

Lyons, KE, JH Friedman, N Hermanowicz, SH Isaacson, RA Hauser, BP Hersh, DE Silver, et al. 2010. “Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects”. Clin Neuropharmacol.